|
|
|
|
| LEADER |
01673cam a2200457 4500 |
| 001 |
PPN078535492 |
| 005 |
20220110055500.0 |
| 010 |
|
|
|a 2-84299-482-5
|b br.
|d 65 EUR
|
| 010 |
|
|
|a 2-8429-9482-5
|b br.
|d 65 EUR
|
| 035 |
|
|
|a 079678262
|
| 073 |
|
1 |
|a 9782842994822
|
| 100 |
|
|
|a 20040525d2004 k y0frey0103 ba
|
| 101 |
0 |
|
|a fre
|
| 102 |
|
|
|a FR
|
| 105 |
|
|
|a y a 000yy
|
| 106 |
|
|
|a r
|
| 200 |
1 |
|
|a Suivi thérapeutique pharmacologique
|b Texte imprimé
|e pour l'adaptation de posologie des médicaments
|f coord. Pierre Marquet
|
| 210 |
|
|
|a Paris
|c Elsevier
|d DL 2004
|
| 215 |
|
|
|a 1 vol. (539 p.)
|d 24 cm
|
| 225 |
2 |
|
|a Collection Option/Bio
|x 0926-9517
|v 2004
|
| 320 |
|
|
|a Notes bibliogr.
|
| 410 |
|
| |
|0 002260565
|t Collection option/bio
|x 0926-9517
|v 2004
|
| 606 |
|
|
|3 PPN027246647
|a Pharmacocinétique
|2 rameau
|
| 606 |
|
|
|3 PPN027389391
|a Médicaments
|x Interaction
|2 rameau
|
| 606 |
|
|
|3 PPN027578747
|a Médicaments
|x Prescription
|2 rameau
|
| 606 |
|
|
|3 PPN027423719
|a Posologie
|2 rameau
|
| 606 |
|
|
|3 PPN031213553
|a Médicaments
|x Relations dose-effet
|2 rameau
|
| 606 |
|
|
|3 PPN027313883
|a Pharmacologie clinique
|2 rameau
|
| 606 |
|
|
|3 PPN04075801X
|a Pharmacologie clinique
|2 fmesh
|
| 606 |
|
|
|3 PPN040697002
|a Utilisation médicament
|2 fmesh
|
| 606 |
|
|
|3 PPN040686361
|a Continuité des soins
|2 fmesh
|
| 606 |
|
|
|3 PPN040696952
|a Chimiothérapie
|2 fmesh
|
| 676 |
|
|
|a 378.61
|v 99
|
| 676 |
|
|
|a 610
|v 99a
|
| 686 |
|
|
|a QV 748
|2 usnlm
|
| 686 |
|
|
|a WB 330
|2 usnlm
|
| 702 |
|
1 |
|3 PPN057868719
|a Marquet
|b Pierre
|f 19..-....
|c pharmacologue
|4 651
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20060531
|g AFNOR
|
| 930 |
|
|
|5 441092101:286596210
|b 441092101
|a WB 330 SUI
|j u
|
| 979 |
|
|
|a SAN
|
| 998 |
|
|
|a 475084
|
Nantilus
